1. Establishment and Characterization of a Human Small Cell Osteosarcoma Cancer Stem Cell Line: A New PossibleIn VitroModel for Discovering Small Cell Osteosarcoma Biology
   Gaia Palmini et al, 2016, Stem Cells International CrossRef
2. Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies
   Ander Abarrategi et al, 2016, Stem Cells International CrossRef
3. Downregulation of DNA-PKcs suppresses P-gp expression via inhibition of the Akt/NF-κB pathway in CD133-positive osteosarcoma MG-63 cells
   Ka Li et al, 2016 CrossRef
4. MicroRNA-29b-1 impairs in vitro cell proliferation, self-renewal and chemoresistance of human osteosarcoma 3AB-OS cancer stem cells
   RICCARDO DI FIORE et al, 2014 CrossRef
5. Mesenchymal stroma: Role in osteosarcoma progression.
   Margherita Cortini et al, 2017, Cancer Lett CrossRef
6. Establishment and characterization of human osteosarcoma cells resistant to pyropheophorbide-α methyl ester-mediated photodynamic therapy
   Yong Tao et al, 2017 CrossRef
7. Immunotherapeutic Concepts to Target Acute Myeloid Leukemia: Focusing on the Role of Monoclonal Antibodies, Hypomethylating Agents and the Leukemic Microenvironment
   Olumide Gbolahan et al, 2017, IJMS CrossRef
8. Targeted salinomycin delivery with EGFR and CD133 aptamers based dual-ligand lipid-polymer nanoparticles to both osteosarcoma cells and cancer stem cells
   Fangyi Chen et al, 2018, Nanomedicine: Nanotechnology, Biology and Medicine CrossRef
9. Novel molecular insights and new therapeutic strategies in osteosarcoma
   Babak Otoukesh et al, 2018, Cancer Cell Int CrossRef
10. Lipid-polymer nanoparticles with CD133 aptamers for targeted delivery of all-trans retinoic acid to osteosarcoma initiating cells
    Keke Gui et al, 2019, Biomedicine & Pharmacotherapy CrossRef
11. null
    Maxim Yu. Rykov et al, 2019 CrossRef
12. Isolation, Culture and Characterization of Cancer Stem Cells from Primary Osteosarcoma
    Achmad Fauzi Kamal et al, 2018, TOSCJ CrossRef
13. null
    Yangyang Wang et al, 2013 CrossRef
14. null
    Kristina Schiavone et al, 2019 CrossRef
15. Targeting of CXCR1 on Osteosarcoma Circulating Tumor Cells and Precise Treatment via Cisplatin Nanodelivery
    Xiu-guo Han et al, 2019, Adv. Funct. Mater. CrossRef
16. Osteosarcoma – on the way to personalized therapy. Part II: personalized therapy of the future
    M. Yu. Rykov et al, 2019, Ross. vestn. perinatol. pediatr. CrossRef
17. Update on Targets and Novel Treatment Options for High-Grade Osteosarcoma and Chondrosarcoma
    Jolieke G. van Oosterwijk et al, 2013, Hematology/Oncology Clinics of North America CrossRef
18. Mucins and tumor resistance to chemotherapeutic drugs
    Nicolas Jonckheere et al, 2014, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
19. Advances in osteosarcoma stem cell research and opportunities for novel therapeutic targets.
    Guang-Ning Yan et al, 2016, Cancer Lett CrossRef
20. Cancer stem cells in osteosarcoma.
    Hannah K Brown et al, 2017, Cancer Lett CrossRef
21. Prospects for the involvement of cancer stem cells in the pathogenesis of osteosarcoma
    Sama Izadpanah et al, 2019, J Cell Physiol CrossRef
22. The inhibition of MARK2 suppresses cisplatin resistance of osteosarcoma stem cells by regulating DNA damage and repair
    Liang Xu et al, 2020, Journal of Bone Oncology CrossRef
23. A molecular pathology method for sequential fluorescence in situ hybridization for multi-gene analysis at the single-cell level
    Linping Hu et al, 2017, Oncotarget CrossRef
24. FOXC2 augments tumor propagation and metastasis in osteosarcoma
    Maricel C. Gozo et al, 2016, Oncotarget CrossRef
25. Development and characterization of cancer stem cell-based tumoroids as an osteosarcoma model.
    Sukru Ozturk et al, 2020, Biotechnol Bioeng CrossRef
26. Epidermal growth factor receptor aptamer‑conjugated polymer‑lipid hybrid nanoparticles enhance salinomycin delivery to osteosarcoma and cancer stem cells
    Zuochong Yu et al, 2017, Exp Ther Med CrossRef
27. Significance of cyclooxygenase‑2, prostaglandin E2 and CD133 levels in sunitinib‑resistant renal cell carcinoma
    Lei Luo et al, 2019, Oncol Lett CrossRef
28. Analysis of microRNA expression in CD133 positive cancer stem‑like cells of human osteosarcoma cell line MG-63
    Xiong Shu et al, 2021 CrossRef
29. null
    Marta Téllez-Gabriel et al, 2022 CrossRef
30. null
    René Rodríguez et al, 2022 CrossRef
31. Cancer Stem Cells and their Management in Cancer Therapy
    Suzan Shenouda et al, 2020, PRA CrossRef
32. The role of dietary polyphenols in osteosarcoma: A possible clue about the molecular mechanisms involved in a process that is just in its infancy
    Ana Carolina Silveira Rabelo et al, 2022, Journal of Food Biochemistry CrossRef
33. Advances in the research of osteosarcoma stem cells and its related genes
    Weifei Zhang et al, 2022, Cell Biology International CrossRef
34. Targeted Delivery of Chemotherapeutic Agents for Osteosarcoma Treatment
    Duoli Xie et al, 2022, Front. Oncol. CrossRef
35. The Role of Tumor Microenvironment in Regulating the Plasticity of Osteosarcoma Cells
    Boren Tian et al, 2022, IJMS CrossRef
36. Identification of Methylation Signatures and Rules for Sarcoma Subtypes by Machine Learning Methods
    Jingxin Ren et al, 2022, BioMed Research International CrossRef
37. Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics
    Pengzhi Shi et al, 2023, J Nanobiotechnol CrossRef
38. Cancer Stem Cells in Sarcomas: In Vitro Isolation and Role as Prognostic Markers: A Systematic Review
    Maria Angeles Chico et al, 2023, Cancers CrossRef
39. Cellular and Genetic Background of Osteosarcoma
    Inga Urlić et al, 2023, CIMB CrossRef
40. Affinity-Based Magnetic Nanoparticle Development for Cancer Stem Cell Isolation
    Cansu İlke Kuru et al, 2024, Polymers CrossRef